These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33583075)

  • 1. Toward efficient generation, correction, and properties control of unique drug-like structures.
    Druchok M; Yarish D; Gurbych O; Maksymenko M
    J Comput Chem; 2021 Apr; 42(11):746-760. PubMed ID: 33583075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian molecular design with a chemical language model.
    Ikebata H; Hongo K; Isomura T; Maezono R; Yoshida R
    J Comput Aided Mol Des; 2017 Apr; 31(4):379-391. PubMed ID: 28281211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional Molecular Design with Deep Generative Models.
    Kang S; Cho K
    J Chem Inf Model; 2019 Jan; 59(1):43-52. PubMed ID: 30016587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep Learning to Generate
    Colby SM; Nuñez JR; Hodas NO; Corley CD; Renslow RR
    Anal Chem; 2020 Jan; 92(2):1720-1729. PubMed ID: 31661259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shape-Based Generative Modeling for de Novo Drug Design.
    Skalic M; Jiménez J; Sabbadin D; De Fabritiis G
    J Chem Inf Model; 2019 Mar; 59(3):1205-1214. PubMed ID: 30762364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep reinforcement learning for de novo drug design.
    Popova M; Isayev O; Tropsha A
    Sci Adv; 2018 Jul; 4(7):eaap7885. PubMed ID: 30050984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico prediction of drug-induced rhabdomyolysis with machine-learning models and structural alerts.
    Cui X; Liu J; Zhang J; Wu Q; Li X
    J Appl Toxicol; 2019 Aug; 39(8):1224-1232. PubMed ID: 31006880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo drug design by iterative multiobjective deep reinforcement learning with graph-based molecular quality assessment.
    Fang Y; Pan X; Shen HB
    Bioinformatics; 2023 Apr; 39(4):. PubMed ID: 36961341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creating the New from the Old: Combinatorial Libraries Generation with Machine-Learning-Based Compound Structure Optimization.
    Podlewska S; Czarnecki WM; Kafel R; Bojarski AJ
    J Chem Inf Model; 2017 Feb; 57(2):133-147. PubMed ID: 28158942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A spatial-temporal gated attention module for molecular property prediction based on molecular geometry.
    Li C; Wang J; Niu Z; Yao J; Zeng X
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current limits in virtual screening and property prediction.
    Hutter MC
    Future Med Chem; 2018 Jul; 10(13):1623-1635. PubMed ID: 29953247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep Convolutional Neural Networks for the Prediction of Molecular Properties: Challenges and Opportunities Connected to the Data.
    Ståhl N; Falkman G; Karlsson A; Mathiason G; Boström J
    J Integr Bioinform; 2018 Dec; 16(1):. PubMed ID: 30517077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOG: Fragment Optimized Growth algorithm for the de novo generation of molecules occupying druglike chemical space.
    Kutchukian PS; Lou D; Shakhnovich EI
    J Chem Inf Model; 2009 Jul; 49(7):1630-42. PubMed ID: 19527020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing molecular graphs with descriptors for the prediction of chemical reaction yields.
    Yarish D; Garkot S; Grygorenko OO; Radchenko DS; Moroz YS; Gurbych O
    J Comput Chem; 2023 Jan; 44(2):76-92. PubMed ID: 36264601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FSM-DDTR: End-to-end feedback strategy for multi-objective De Novo drug design using transformers.
    Monteiro NRC; Pereira TO; Machado ACD; Oliveira JL; Abbasi M; Arrais JP
    Comput Biol Med; 2023 Sep; 164():107285. PubMed ID: 37557054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular graph convolutions: moving beyond fingerprints.
    Kearnes S; McCloskey K; Berndl M; Pande V; Riley P
    J Comput Aided Mol Des; 2016 Aug; 30(8):595-608. PubMed ID: 27558503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adversarial deep evolutionary learning for drug design.
    Abouchekeir S; Vu A; Mukaidaisi M; Grantham K; Tchagang A; Li Y
    Biosystems; 2022 Dec; 222():104790. PubMed ID: 36228831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De Novo Molecular Design by Combining Deep Autoencoder Recurrent Neural Networks with Generative Topographic Mapping.
    Sattarov B; Baskin II; Horvath D; Marcou G; Bjerrum EJ; Varnek A
    J Chem Inf Model; 2019 Mar; 59(3):1182-1196. PubMed ID: 30785751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a drug-like natural product library.
    Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
    J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magicmol: a light-weighted pipeline for drug-like molecule evolution and quick chemical space exploration.
    Chen L; Shen Q; Lou J
    BMC Bioinformatics; 2023 Apr; 24(1):173. PubMed ID: 37101113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.